Chapter References

1. Myers, R., Spinks, T.J., Luthra, S.K., et al. (1992). Positron emission tomography. In Quantitative methods in neuroanatomy (ed. M.G. Stewart), pp. 117-61. Wiley, New York.

2. Myers, R., Cunningham, V., Bailey, D., and Jones, T. (1996). Quantification of brain function using PET. Academic Press, London.

3. Friston, K.J., Holmes, A.P., Worsley, K.J., et al. (1995). Statistical parametric maps in functional imaging: a general linear approach. Human Brain Mapping, 2, 189-210.

4. Frackowiak, R.S.J., Friston, K.J., Frith, C.D., Dolan, R.J., and Mazziotta, J.C. (1997). Human brain function. Academic Press, San Diego, CA.

5. Grasby, P., Malizia, A., and Bench, C. (1996). Psychopharmacology— in vivo neurochemistry and pharmacology. British Medical Bulletin, 52, 513-26.

6. Raichle, M.E. (1987). Circulatory and metabolic correlations of brain function in normal humans. In Handbook of physiology. Section 1, The nervous system. Vol. 5, Higher functions of the brain (ed. F. Plum), pp. 643-74. Oxford University Press, New York.

7. Wong, D.F., Wagner, H.N., Tune, L.E., et al. (1986). Positron emission tomography reveals elevated D2-dopamine receptors in drug-naive schizophrenia. Science, 234, 1558-63.

8. Farde, L., Wiesel, F.-A., Stone-Elander, S., et al. (1990). D2 dopamine receptors in neuroleptic naive schizophrenic patients. Archives of General Psychiatry, 47, 213-19.

9. Sedvall, G. and Farde, L. (1995). Chemical brain anatomy in schizophrenia. Lancet, 346, 743-9.

10. Hietala, J., Syvalahti, E., and Vuorio, K., et al. (1995). Presynaptic dopamine function in striatum of neuroleptic naive schizophrenic patients. Lancet, 346, 1130-1.

11. Okubo, Y., Suhara, T., Suzuku, K., et al. (1997). Decreased prefrontal dopamine D1 receptors in schizophreia revealed by PET. Nature, 385, 634-6.

12. Volkow, N.D, Wang, G.-J., Fowler, J.S., et al. (1994). Imaging endogenous dopamine competition with 11C-raclopride in the human brain. Synapse, 16, 255-62

13. Laruelle, M., Abi-Dargham, A., van Dyck, C.H., et al. (1996). Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenia subjects. Proceedings of the National Academy of Sciences of the United States of America, 93, 9235-40.

14. Weinberger, D.R. and Berman, K.F. (1996). Prefrontal function in schizophrenia: confounds and controversies. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 351, 1495-503.

15. Chuam, S.E. and McKenna, P.J. (1996). Schizophrenia—a brain disease? A critical review of structural and functional cerebral abnormality in the disorder. British Journal of Psychiatry, 166, 563-82.

16. Frith, C.D., Friston, K.J., Herold, S., et al. (1995). Regional brain activity in chronic schizophrenic patients during the performance of a verbal fluency task. British Journal of Psychiatry, 167, 343-9.

17. Liddle, P.F., Friston, K.J., Frith, C.D., Hirsch, S.R., Jones, T., and Frackowiak, R.S.J. (1992). Patterns of cerebral blood flow in schizophrenia. British Journal of Psychiatry, 160, 179-86.

18. Dolan, R.J., Bench, C.J., Liddle, P.F., et al. (1993). Dorsolateral prefrontal cortex dysfunction in the major psychoses; symptom or disease specificity? Journal of Neurology, Neurosurgery and Psychiatry, 56, 1290-4.

19. Andreasen, N.C., O'Leary, D.S., Flaum, M., et al. (1997). Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients. Lancet, 349, 1730-4.

20. Sabri, O., Erkwoh, R., Schreckenberger, M., et al. (1997). Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics. Lancet, 349, 1735-9.

21. Spence, S.A., Hirsch, S.R., Brooks, D.J., and Grasby, P.M. (1998). Prefrontal cortex activity in people with schizophrenia and control subjects. Evidence from positron emission tomography for remission of 'hypofrontality' with recovery from acute schizophrenia. British Journal of Psychiatry, 172, 316-23.

22. Pike, V., McCarron, J.A., Lammerstma, A.A., et al. (1995). First delineation of 5-HT1A receptors in the living human brain using 11C-WAY-100635. European Journal of Pharmacology, 283, R1-R3.

23. Pike, V. (1993). Positron emitting radioligands for studies in vivo—probes for human psychopharmacology. Journal of Psychopharmacology, 7, 139-58.

24. Goodwin, G. (1996). Functional imaging, affective disorder and dementia. British Medical Bulletin, 52, 495-512.

25. Bench, C.J., Friston, K.J., Brown, R.G., et al. (1993). Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions. Psychological Medicine, 23, 579-90.

26. Drevets, W.C., Price, J.L., Simpson, J.R., et al. (1997). Subgenual prefrontal cortex abnormalities in mood disorders. Nature, 386, 824-7.

27. Grasby, P.M. and Bench, C.J. (1997). Neuroimaging of mood disorders. Current Opinion in Psychiatry, 10, 73-8.

28. Farde, L., Nordstrom, A.-L., Wiesel, F.A., Pauli, S., Halldin, C., and Sedvall, G. (1992). Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Archives of General Psychiatry, 49, 538-54.

29. Nyberg, S., Farde, L., and Erikson, L. (1993). 5-HT2 and D2 dopamine receptor occupancy in the living human brain: a PET study with risperidone. Psychopharmacology, 110, 265-72.

Positive Thinking Power Play

Positive Thinking Power Play

Learning About A Positive Thinking Power Play Can Have Amazing Benefits For Your Life And Success. Learn About Positive Thinking Power Play -And Have A Look At 10 Steps to Success To Create Amazing Results.

Get My Free Ebook


Post a comment